First Light Asset Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,577,880
Closed -$134M 81
2020
Q3
$134M Sell
1,577,880
-90,860
-5% -$4.59M 13.75% 1
2020
Q2
$59.1M Sell
1,668,740
-348,363
-17% -$10.2M 6.89% 3
2020
Q1
$27.2M Buy
2,017,103
+771,860
+62% +$13M 4.64% 5
2019
Q4
$26.3M Sell
1,245,243
-5,293
-0.4% -$93.4K 3.37% 11
2019
Q3
$16.6M Buy
1,250,536
+27,053
+2% +$398K 2.51% 15
2019
Q2
$17M Sell
1,223,483
-181,230
-13% -$2.73M 2.36% 17
2019
Q1
$27M Buy
1,404,713
+44,433
+3% +$716K 3.51% 10
2018
Q4
$19.4M Buy
1,360,280
+208,658
+18% +$4.14M 3.09% 14
2018
Q3
$24M Sell
1,151,622
-5,876
-0.5% -$139K 3.87% 10
2018
Q2
$27.4M Buy
1,157,498
+137,578
+13% +$2.77M 4.27% 9
2018
Q1
$14.9M Buy
1,019,920
+75,516
+8% +$1.23M 3.27% 11
2017
Q4
$15.3M Sell
944,404
-367,110
-28% -$4.33M 4.19% 9
2017
Q3
$18.3M Sell
1,311,514
-737,129
-36% -$7.35M 5.81% 3
2017
Q2
$18.1M Sell
2,048,643
-47,852
-2% -$336K 6.07% 4
2017
Q1
$13.6M Sell
2,096,495
-185,514
-8% -$940K 5.18% 4
2016
Q4
$8.38M Buy
2,282,009
+1,289,142
+130% +$3.81M 3.68% 7
2016
Q3
$3.23M Buy
992,867
+5,013
+0.5% +$14K 1.39% 31
2016
Q2
$2.29M Sell
987,854
-555,688
-36% -$1.86M 1.06% 34
2016
Q1
$3.86M Buy
1,543,542
+692,785
+81% +$1.56M 1.95% 21
2015
Q4
$2.61M Buy
+850,757
New +$2.37M 1.09% 33

First Light Asset Management's IMMU Position: Q4 2020 in Review

First Light Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,577,880 shares — an estimated $134M sold.

First Light Asset Management first reported a position in IMMU in Q4 2015 and held it in 20 quarters. The position peaked at $134M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • First Light Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • First Light Asset Management sold 1,577,880 Immunomedics Inc shares in Q4 2020, an estimated $134M.
  • First Light Asset Management first reported a position in Immunomedics Inc in Q4 2015 and held it in 20 quarters.
  • First Light Asset Management's Immunomedics Inc position peaked at $134M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on First Light Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.